Proteome analysis of NRF2 inhibition in melanoma reveals CD44 up-regulation and increased apoptosis resistance upon vemurafenib treatment

HP Weitzenbock; A Gschwendtner; C Wiesner; M Depke; F Schmidt; F Trautinger; M Hengstschlager; H Hundsberger; M Mikula

doi:10.1002/cam4.4506

Proteome analysis of NRF2 inhibition in melanoma reveals CD44 up-regulation and increased apoptosis resistance upon vemurafenib treatment

HP Weitzenbock
, A Gschwendtner
, C Wiesner
, M Depke
, F Schmidt
, F Trautinger
, M Hengstschlager
, H Hundsberger
, M Mikula

Department of Dermatology and Allergology

Research output: Contribution to journal › Original Article › peer-review

12 Citations (Web of Science)

Original language	English
Journal	CANCER MEDICINE
DOIs	https://doi.org/10.1002/cam4.4506
Publication status	Published - 2022

Keywords

TRANSCRIPTION FACTOR NRF2
C-MYC
EXPRESSION
GENE
CELLS
IDENTIFICATION
METASTASIS
ACTIVATION
PATHWAYS
DRIVES

Access to Document

10.1002/cam4.4506

Cite this

@article{fcdebbb921ed46afb39925888cd8566b,

title = "Proteome analysis of NRF2 inhibition in melanoma reveals CD44 up-regulation and increased apoptosis resistance upon vemurafenib treatment",

keywords = "TRANSCRIPTION FACTOR NRF2, C-MYC, EXPRESSION, GENE, CELLS, IDENTIFICATION, METASTASIS, ACTIVATION, PATHWAYS, DRIVES",

author = "HP Weitzenbock and A Gschwendtner and C Wiesner and M Depke and F Schmidt and F Trautinger and M Hengstschlager and H Hundsberger and M Mikula",

note = "Hundsberger: Department of Dermatology, University Hospital of the Paracelsus Medical University, Salzburg, Austria",

year = "2022",

doi = "10.1002/cam4.4506",

language = "English",

journal = "CANCER MEDICINE",

issn = "2045-7634",

publisher = "Wiley Verlag ",

}

TY - JOUR

T1 - Proteome analysis of NRF2 inhibition in melanoma reveals CD44 up-regulation and increased apoptosis resistance upon vemurafenib treatment

AU - Weitzenbock, HP

AU - Gschwendtner, A

AU - Wiesner, C

AU - Depke, M

AU - Schmidt, F

AU - Trautinger, F

AU - Hengstschlager, M

AU - Hundsberger, H

AU - Mikula, M

N1 - Hundsberger: Department of Dermatology, University Hospital of the Paracelsus Medical University, Salzburg, Austria

PY - 2022

Y1 - 2022

KW - TRANSCRIPTION FACTOR NRF2

KW - C-MYC

KW - EXPRESSION

KW - GENE

KW - CELLS

KW - IDENTIFICATION

KW - METASTASIS

KW - ACTIVATION

KW - PATHWAYS

KW - DRIVES

U2 - 10.1002/cam4.4506

DO - 10.1002/cam4.4506

M3 - Original Article

C2 - 34951143

SN - 2045-7634

JO - CANCER MEDICINE

JF - CANCER MEDICINE

ER -